Cargando…
Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849486/ http://dx.doi.org/10.1016/j.ymgme.2020.12.080 |
| _version_ | 1783645312519241728 |
|---|---|
| author | Frey, Aline Trokan, Luba Vogler, Markus Hughes, Derralynn Gimona, Alberto |
| author_facet | Frey, Aline Trokan, Luba Vogler, Markus Hughes, Derralynn Gimona, Alberto |
| author_sort | Frey, Aline |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7849486 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Academic Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78494862021-02-02 Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease Frey, Aline Trokan, Luba Vogler, Markus Hughes, Derralynn Gimona, Alberto Mol Genet Metab Article Academic Press 2021-02 2021-02-01 /pmc/articles/PMC7849486/ http://dx.doi.org/10.1016/j.ymgme.2020.12.080 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Frey, Aline Trokan, Luba Vogler, Markus Hughes, Derralynn Gimona, Alberto Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title | Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title_full | Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title_fullStr | Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title_full_unstemmed | Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title_short | Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease |
| title_sort | measures to mitigate disruption due to the covid-19 pandemic of the modify phase 3 pivotal trial in patients with fabry disease |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849486/ http://dx.doi.org/10.1016/j.ymgme.2020.12.080 |
| work_keys_str_mv | AT freyaline measurestomitigatedisruptionduetothecovid19pandemicofthemodifyphase3pivotaltrialinpatientswithfabrydisease AT trokanluba measurestomitigatedisruptionduetothecovid19pandemicofthemodifyphase3pivotaltrialinpatientswithfabrydisease AT voglermarkus measurestomitigatedisruptionduetothecovid19pandemicofthemodifyphase3pivotaltrialinpatientswithfabrydisease AT hughesderralynn measurestomitigatedisruptionduetothecovid19pandemicofthemodifyphase3pivotaltrialinpatientswithfabrydisease AT gimonaalberto measurestomitigatedisruptionduetothecovid19pandemicofthemodifyphase3pivotaltrialinpatientswithfabrydisease |